Burkholderia pseudomallei isocitrate lyase is a persistence factor in pulmonary melioidosis: Implications for the development of isocitrate lyase inhibitors as novel antimicrobials

Infection and Immunity

Volumn 77, Issue 10, 2009, Pages 4275-4283

  Van Schaik, Erin J ^a   Tom, Marina ^a   Woods, Donald E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; ISOCITRATE LYASE; ITACONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; DEATH; ENZYME ACTIVITY; ENZYME INHIBITION; LUNG INFECTION; MALE; MELIOIDOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PULMONARY MELIOIDOSIS; RAT; TUBERCULOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BURKHOLDERIA PSEUDOMALLEI; COLONY COUNT, MICROBIAL; ENZYME INHIBITORS; ISOCITRATE LYASE; LETHAL DOSE 50; LUNG; MELIOIDOSIS; RATS; SURVIVAL ANALYSIS;

EID: 70349420958     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00609-09     Document Type: Article

References (39)

1. Banerjee, S. A., K. Nandyala, P. Raviprasad, N. Ahmed, and S. E. Hasnain. 2007. Iron-dependent RNA-binding activity of Mycobacterium tuberculosis aconitase. J. Bacteriol. 189:4046-4052.
2. Burtnick, M. N., P. J. Brett, V. Nair, J. M. Warawa, D. E. Woods, and F. C. Gherardini. 2008. Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages. Infect. Immun. 76:2991-3000.
3. Choi, K. H., D. DeShazer, and H. P. Schweizer. 2006. Mini-Tn7 insertion in bacteria with multiple glmS-linked attTn7 sites: example Burkholderia mallei ATCC 23344. Nat. Protoc. 1:162-169.
4. Currie, B. J., D. A. Dance, and A. C. Cheng. 2008. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl. 1):1-4.
5. Dance, D. A. B. 1991. Melioidosis: the tip of the iceberg? Clin. Microbiol. Rev. 4:52-60.
6. deLorenzo, V., and K. N. Timmis. 1994. Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons. Methods Enzymol. 235:386-405.
7. Fang, F. C., S. J. Libby, M. E. Castor, and A. M. Fung. 2005. Isocitrate lyase (AceA) is required for Salmonella persistence but not for acute lethal infection in mice. Infect. Immun. 73:2547-2549.
8. Gan, Y. H. 2005. Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy? J. Infect. Dis. 192:1845-1850.
9. Gould, T. A., H. van de Langemheen, E. J. Muñoz-Elías, J. D. McKinney, and J. C. Sacchettini. 2006. Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis. Mol. Microbiol. 61:940-947.
10. Guy, E. S., and A. Mallampalli. 2008. Managing TB in the 21st century: existing and novel drug therapies. Ther. Adv. Respir. Dis. 2:401-408.
11. Heckman, K. L., and L. R. Pease. 2007. Gene splicing and mutagenesis by PCR-driven overlap extension. Nat. Protoc. 2:924-932.
12. Hiler, S., and W. T. Charnetzky. 1981. Glyoxylate bypass enzymes in Yersinia species and multiple forms of isocitrate lyase in Yersinia pestis. J. Bacteriol. 145:452-458.
13. Ip, M., G. Lars, P. Y. Osterberg, and T. Raffin. 1995. Pulmonary melioidosis. Chest 108:1420-1424.
14. Jun-Ming, L., L. Na, Z. Dao-Yin, W. La-Gen, H. Yong-Lin, and Y. Chun. 2008. Isocitrate lyase from Mycobacterium tuberculosis promotes survival of Mycobacterium smegmatis within macrophage by suppressing cell apoptosis. Chin. Med. J. 121:1114-1119.
15. Kanehisa, M., and S. Goto. 2000. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27-30. (Pubitemid 30047706)
16. Lindsey, T. L., J. M. Hagins, P. A. Sokol, and L. A. Silo-Suh. 2008. Virulence determinants from a cystic fibrosis isolate of Pseudomonas aeruginosa include isocitrate lyase. Microbiology 154:1616-1627.
17. McKinney, J. D., K. Honer ze Bentrup, E. J. Muñoz-Elías, A. Miczak, B. Chen, W. T. Chan, D. Swenson, J. C. Sacchettini, W. R. Jacobs, Jr., and D. G. Russell. 2000. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735-738.
18. Moore, R. A., D. DeShazer, S. Reckseidler, A. Weissman, and D. E. Woods. 1999. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 43:465-470.
19. Moore, R. A., S. Reckseidler-Zenteno, H. Kim, W. Nierman, Y. Yu, A. Tuanyok, J. Warawa, D. DeShazer, and D. E. Woods. 2004. Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei. Infect. Immun. 72:4172-4187.
20. Moore, R. A., A. Tuanyok, and D. E. Woods. 2008. Survival of Burkholderia pseudomallei in water. BMC Res. Notes 7:1-11.
21. Muñoz-Elías, E. J., and J. D. McKinney. 2005. Mycobacterium tuberculosis isocitrate lyase 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11:638-644.
22. Muñoz-Elías, E. J., and J. D. McKinney. 2006. Carbon metabolism of intracellular bacteria. Cell. Microbiol. 8:10-22.
23. Muñoz-Elías, E. J., A. M. Upton, J. Cherian, and J. D. McKinney. 2006. Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence. Mol. Microbiol. 60:1109-1122.
24. My, L., and T. H. Ottenhoff. 2008. Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection. Biol. Chem. 389:497-511.
25. Overtoom, R., V. Khieu, S. Hem, P. Cavailler, V. Te, S. Chan, P. Lau, B. Guillard, and S. Vong. 2008. A first report of pulmonary melioidosis in Cambodia. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl. 1):21-25.
26. Peacock, S. J., H. P. Schweizer, D. A. Dance, T. L. Smith, J. E. Gee, V. Wuthiekanun, D. DeShazer, I. Steinmetz, P. Tan, and B. J. Currie. 2008. Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg. Infect. Dis. 14:e2.
27. Reckseidler-Zenteno, S., R. DeVinney, and D. E. Woods. 2005. The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition. Infect. Immun. 73:1106-1115.
28. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
29. Schappinger, D., S. Ehrt, M. I. Voskuil, Y. Liu, J. A. Mangan, I. M. Monahan, G. Dolganov, B. Efron, P. D. Butcher, C. Nathan, and G. K. Schoolnik. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insight into the phagosomal environment. J. Exp. Med. 198:693-704.
30. Skorupski, K., and R. K. Taylor. 1996. Positive selection vectors for allelic exchange. Gene 169:47-52. (Pubitemid 26075696)
31. Somerville, G., C. A. Mikoryak, and L. Reitzer. 1999. Physiological characterization of Pseudomonas aeruginosa during exotoxin A synthesis: glutamate, iron limitation, and aconitase activity. J. Bacteriol. 181:1072-1078.
32. Somerville, G. A., B. Said-Salim, J. M. Wickman, S. J. Raffel, B. N. Kreiswirth, and J. M. Musser. 2003. Correlation of acetate catabolism and growth yield in Staphylococcus aureus: implications for host-pathogen interactions. Infect. Immun. 71:4724-4732.
33. Thomas, D. C. 2008. Cows, Crohn's and more: is Mycobacterium paratuberculosis a superantigen? Med. Hypotheses 71:838-861.
34. Tuanyok, A., B. R. Leadem, R. K. Auerbach, S. M. Beckstrom-Sternberg, J. S. Beckstrom-Sternberg, M. Mayo, V. Wuthiekanun, T. S. Brettin, W. C. Nierman, S. J. Peacock, B. J. Currie, D. M. Wagner, and P. Keim. 2008. Genomic islands from five strains of Burkholderia pseudomallei. BMC Genomics 9:566-583.
35. Upton, A. M., and J. D. McKinney. 2007. Role of the methylcitrate cycle in propionate metabolism and detoxification in Mycobacterium smegmatis. Microbiology 153:3973-3982.
36. van Schaik, E., M. Tom, R. DeVinney, and D. E. Woods. 2008. Development of novel animal infection models for the study of acute and chronic Burkholderia pseudomallei pulmonary infections. Microbes Infect. 10:1291-1299.
37. Vidyalakshimi, K., M. Chakrapani, B. Shrikala, S. Damodar, S. Lipika, and S. Vishal. 2008. Tuberculosis mimicked by melioidosis. Int. J. Tuberc. Lung Dis. 12:1209-1215.
38. Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.
39. White, N. J. 2003. Melioidosis. Lancet 361:1715-1722.